Frusemide 40 mg Tablets

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Furosemide

Available from:

Dechra Limited

ATC code:

QC03CA01

INN (International Name):

Furosemide

Pharmaceutical form:

Tablet

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cats, Dogs

Therapeutic area:

Cardio Vascular diuretic

Authorization status:

Authorized

Authorization date:

2003-05-21

Summary of Product characteristics

Revised: March 2022
AN: 02253/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Frusemide 40 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
Qualitative composition
Quantitative composition
Furosemide (Frusemide)
40 mg per tablet
EXCIPIENTS
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
White, circular, biconvex, flat-faced tablets with bevelled edges,
with F40 on one side
and CP or DP on the reverse, and a breakline.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of oedema associated with cardiac insufficiency,
renal dysfunction
and trauma in cats and dogs.
In animals with pulmonary oedema of cardiac origin, combined therapy
with other
medicinal products may be indicated.
4.3
CONTRAINDICATIONS
Do not use in animals with acute glomerular nephritis, renal failure
with anuria,
electrolyte deficiency disease or in animals that have received an
overdosage of
digitalis.
Do not use concurrently with aminoglycoside antibiotics.
Do not use in animals weighing less than 4 kg.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
There are no special warnings required for either target species.
Revised: March 2022
AN: 02253/2021
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Do not exceed the recommended dosage.
Therapeutic efficacy may be impaired by increased intake of drinking
water.
Where the animal’s condition permits, water intake should be
restricted during
treatment with Frusemide 40 mg tablets.
Monitoring of plasma potassium levels is advisable during periods of
prolonged treatment of combined therapy with cardiac glycosides.
Potassium
supplements may be necessary.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Wear gloves, or wash your hands immediately after handling the
tablets.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
During t